Sightera Biosciences closes €3M pre-seed to expand its patient-derived AI drug discovery platform

Sightera Biosciences, a Belgiantechbio company using generative AI to develop novel small-molecule therapies,has raised €3 million in a pre-seed funding round led by Entourage, Anacura andQBIC.A spin-...